🏛️ Verified NIH Record • Updated 2025-12-10
Third Party Viral Specific T-cells (VSTs) (NCT02532452)
Third Party Viral Specific T-cells (VSTs) for Treatment of Viral Infections in Immunocompromised Patients
🟢 Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: Children's Hospital Medical Center, Cincinnati
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to demonstrate that viral specific T-cells (a type of white blood cell) can be generated from an unrelated donor and given safely to patients with viral infections.
Who can join: Review the eligibility criteria below.
Location: Akron Children's Hospital — Akron, Ohio
Age range: 2 Days
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- Akron Children's Hospital — Akron, Ohio
- University of Cincinnati Medical Center — Cincinnati, Ohio
- Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio
- The Ohio State University Wexner Medical Center - James Cancer Hospital — Columbus, Ohio
📞 Contact the Study Coordinator
Phone: (513) 803-1102
Email: Jamie.Wilhelm@cchmc.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Viral Infection
- Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis — Washington D.C., District of Columbia
- Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs) — San Francisco, California
- Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts — Washington D.C., District of Columbia
- School Inner City Air Study — Boston, Massachusetts
- TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT. — Houston, Texas
Explore by condition: All Viral Infection clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.